TWiV 961: Clinical update with Dr. Daniel Griffin

In his weekly clinical update Dr. Griffin discusses Mpox (formerly monkeypox) in women: epidemiological features and clinical characteristics of mpox cases in Spain, April to November 2022, triage of patients with Ebola virus disease, SARS-CoV-2 serology and self-reported infection among adults, serological markers of SARS-CoV-2 infection; anti-nucleocapsid antibody positivity may not be the ideal marker of natural infection in vaccinated individuals, sensitivity of anti-SARS-CoV-2 nucleocapsid protein antibody for breakthrough infections during the epidemic of the Omicron variants, effect of wearing glasses on risk of infection with SARS-CoV-2 in the community, and data-driven identification of post-acute SARS-CoV-2 infection subphenotypes. Subscribe (free): Apple Podcasts , Google Podcasts , RSS , email Become a patron of TWiV! Links for this episode Mpox in women: Epidemiological features and clinical characteristics of cases (Eurosurveillance) Triage of patients with Ebola virus disease (The Lancet) SARS-CoV-2 serology and self-reported infection among adults (CDC) Serological markers of SARS-CoV-2 infection (JID) Sensitivity of anti-SARS-CoV-2 nucleocapsid protein antibody (Journal of infection) Effect of wearing glasses on risk of infection with SARS-CoV-2 in the community (JAMA) Paxlovid patient eligbiliity screening checklist (FDA) Data-driven identification of post-acute SARS-CoV-2 infection subphenotypes (Nature) Contribute to our MicrobeTV fundraiser at PWB Dr. Griffin's treatment guide ( pdf) Letters read on TWiV 961 Timestamps by Jolene . Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]